U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Increase the proportion of adults with diabetes and chronic kidney disease who get ACE inhibitors or ARBs — CKD‑05 Data

Status: Little or no detectable change

  Little or no detectable change
Learn more about our data release schedule

Most Recent Data:
49.2 percent (2017-20) *

Target:
58.6 percent  *

Desired Direction:
Increase desired

Baseline:
46.2 percent of adults aged 18 years and over with diagnosed diabetes and chronic kidney disease received recommended medical treatment with ACE inhibitors or ARBs in 2013-16  *

* Age adjusted to the year 2000 standard population.

Download CKD-05 data [CSV]
Disparities data are only available for some selections.

View CI in the chart by hovering over a data point.

View SE in the chart by hovering over a data point.

Confidence Interval (CI) not available Standard Error (SE) not available Confidence Interval (CI) and Standard Error (SE) are not available

Adults with diagnosed diabetes and chronic kidney disease receiving recommended treatment, 2013-16 to 2017-20 * ◊
(percent)
Increase desired

Population 2013-16 2017-20
Total
46.2
CI 41.0 / 51.5
SE 4.458
49.2
CI 43.0 / 55.3
SE 6.117